• CN | EN



    2002 Biochem Established and start to produce fine chemicals in Taihei;

    2007 Joint venture with QVT Strategy in APIs/FPP both China & Global market,esp Anti-Viral;

    2008 Obtained 1st API CMP Certificate at Taihe site (old) ;

    2008 Acquisition of FPP plant in Hefei;

    2010 1st CPP of Lamivudine tab in China;

    2012 Establishment new API site at current location in Taihe;

    2014 API registered in Brazil (Anvisa);

    2014 FPP GMP insepection by Namibia;

    2015 Starting with WHO PQ both APIs and FPP;

    In 2016, passed the on-site audit of the WHO's PQ and obtained WHO GMP certification;

    In 2017, obtained the authorization of the World Pharmaceutical Patent Pool in the series of anti-AIDS drugs;

    In 2018, the China-Africa Health Industry Alliance of CABC was established by the China-Africa Civil Chamber of Commerce. Chairman Wang Zhibang was elected as the first president.